MERCURI-2 – Dapagliflozin and AKI Post Cardiac Surgery

Dapagliflozin and Acute Kidney Injury Following Cardiac Surgery A Randomized Clinical Trial Oosterom-Eijmael et al. JAMA. 2026;336(9):765-773. doi:10.1001/jama.2026.9268 Clinical Question In adults undergoing elective cardiac surgery, does peri-operative dapagliflozin, initiated the day before surgery, compared with placebo, reduce acute kidney injury (AKI) within 7 post-operative days? Background AKI occurs in up to 50% of patients undergoing cardiac surgery and is […]

Continue reading »